Massachusetts General Hosptial (MGH) — Boston, Massachusetts

Massachusetts General Hosptial (MGH) is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hosptial (MGH) has participated in 1 clinical trials.

Therapeutic areas: Desmoid Tumor, Aggressive Fibromatosis.

Sponsors: SpringWorks Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hosptial (MGH)?

Massachusetts General Hosptial (MGH) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hosptial (MGH) conducted?

Massachusetts General Hosptial (MGH) has 1 clinical trials on record. Their work covers Desmoid Tumor, Aggressive Fibromatosis.

Is Massachusetts General Hosptial (MGH) accredited by Crixeo Health?

Massachusetts General Hosptial (MGH) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hosptial (MGH)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.